arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Bio-Techne Corp

TECH Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$72.62
▲ +0.1% Today
as of Oct 22, 16:52 ET
Last 30 days +0.48% Sep 14 → Oct 22
$72.24 $72.35 $72.45 $72.56 $72.67 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$72.56
High
$72.69
Low
$72.51
Volume
$4M
Avg Vol
$3M
Mkt Cap
$11.4B
P/E (TTM)
77.20
Beta
—
52w High
$72.69
52w Low
$43.20
Div Yield
—
Shares Out
$157M

Recent Press Releases & News last 60 days · 6 items

Sep 30 · 14:40 Zacks
INCY or TECH: Which Is the Better Value Stock Right Now?
Sep 26 · 03:57 Insider Monkey
Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package
Sep 23 · 13:41 StockStory
3 Reasons to Sell TECH and 1 Stock to Buy Instead
▸ Show all 6 press releases & news Free account →

TECH earnings at a glance

Bio-Techne Corp (TECH) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of $0.40, compared with $0.36 in the same quarter last year (+11%). The options market is pricing a move of about ±7.2% after the report, a range of roughly $67.41 to $77.83 from today's $72.62. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±5.9% on average; after the most recent report on Aug 12, 2026 it moved +0.1%. That means options currently expect more movement than TECH has typically delivered. TECH beat the consensus EPS estimate in 4 of its last 6 reported quarters. Implied volatility is currently 61%. The share price of $72.62 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$43
$73
100% of range
Avg surprise (last 6)
+7.2%
Avg reaction (last 6)
-3.1%
50% positive
Latest IV / EM
61%
EM ±7.2% · $70 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.17$0.26$0.34$0.43$0.51 Actual $0.31Actual $0.17Actual $0.31Actual $0.21Actual $0.22Actual $0.50Est $0.45Actual $0.51Est $0.46Actual $0.36Est $0.36Actual $0.24Actual $0.39Est $0.34Actual $0.48Est $0.48Actual $0.49Est $0.46 SepDecMarSepDecMar/2025Jun/2025Sep/2025Dec8KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$83M$166M$249M$332M Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 12, 2026Jun/2026 $0.49 $0.46 +6.5% -9.8% +0.1% earnings
Wed May 6, 2026Mar/2026 $0.48 $0.48 0.0% -4.0% -16.4% earnings
Wed Feb 4, 20268K 2026-02-04 $0.39 $0.34 +14.7% — +6.3% earnings
Wed Dec 31, 2025Dec 2025 $0.24 — — — — financials
Wed Nov 5, 2025Sep/2025 $0.36 $0.36 0.0% — -1.9% earnings
Wed Aug 6, 2025Jun/2025 $0.51 $0.46 +10.9% — -8.7% earnings
Wed May 7, 2025Mar/2025 $0.50 $0.45 +11.1% — +2.2% earnings
Tue Dec 31, 2024Dec 2024 $0.22 — — — — financials
Mon Sep 30, 2024Sep 2024 $0.21 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.31 — — — — financials
Sun Dec 31, 2023Dec 2023 $0.17 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.31 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.43 — — — — financials
Sat Dec 31, 2022Dec 2022 $0.31 — — — — financials
Fri Sep 30, 2022Sep 2022 $0.55 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER $0.40$0.36 +11.1%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$311M$296M$287M—$316M$297M$289M—
Cost of revenue$103M$105M$98M—$102M$103M$106M—
Gross profit$208M$191M$188M—$215M$194M$183M—
Operating income$75M$54M$48M—$39M$47M$40M—
Net income$51M$38M$38M—$23M$35M$34M—
EPS (diluted)$0.32$0.24$0.24—$0.14$0.22$0.21—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$210M$173M$145M$162M$141M$178M$188M$152M
Inventory$201M$205M$203M$189M$191M$188M$185M$180M
Total current assets$688M$637M$610M$608M$627M$635M$649M$617M
Total assets$2.55B$2.52B$2.53B$2.56B$2.64B$2.67B$2.74B$2.70B
Long-term debt————————
Total liabilities————————
Total equity$2.09B$2.01B$1.97B$1.92B$2.02B$2.08B$2.14B$2.07B

Implied volatility — last 90 days

7%46%84%123%162% Jun 07 — IV 61% · EM ±8.5%Jun 08 — IV 56% · EM ±7.5%Jun 09 — IV 54% · EM ±6.8%Jun 10 — IV 67% · EM ±7.9%Jun 11 — IV 63% · EM ±7.0%Jun 12 — IV 48% · EM ±4.9%Jun 15 — IV 65% · EM ±4.7%Jun 16 — IV 77% · EM ±4.6%Jun 19 — IV 42% · EM ±9.4%Jun 22 — IV 43% · EM ±8.9%Jun 23 — IV 46% · EM ±9.4%Jun 24 — IV 48% · EM ±9.7%Jun 25 — IV 12% · EM ±2.3%Jun 26 — IV 23% · EM ±4.4%Jun 29 — IV 10% · EM ±1.8%Jun 30 — IV 8% · EM ±1.3%Jul 01 — IV 17% · EM ±2.9%Jul 02 — IV 9% · EM ±1.4%Jul 03 — IV 9% · EM ±1.4%Jul 06 — IV 11% · EM ±1.6%Jul 07 — IV 22% · EM ±2.9%Jul 08 — IV 22% · EM ±2.8%Jul 09 — IV 17% · EM ±2.0%Jul 10 — IV 32% · EM ±3.6%Jul 13 — IV 53% · EM ±4.4%Jul 14 — IV 28% · EM ±2.0%Jul 15 — IV 49% · EM ±2.9%Jul 16 — IV 112% · EM ±4.7%Jul 20 — IV 11% · EM ±2.6%Jul 21 — IV 16% · EM ±3.8%Jul 22 — IV 26% · EM ±6.1%Jul 23 — IV 19% · EM ±4.2%Jul 24 — IV 16% · EM ±3.6%Jul 27 — IV 22% · EM ±4.6%Jul 28 — IV 12% · EM ±2.4%Jul 29 — IV 29% · EM ±5.8%Jul 30 — IV 20% · EM ±3.9%Jul 31 — IV 22% · EM ±4.2%Aug 03 — IV 24% · EM ±4.2%Aug 04 — IV 24% · EM ±4.2%Aug 05 — IV 25% · EM ±4.2%Aug 06 — IV 18% · EM ±2.9%Aug 07 — IV 36% · EM ±5.7%Aug 10 — IV 31% · EM ±4.2%Aug 11 — IV 41% · EM ±5.5%Aug 12 — IV 31% · EM ±3.9%Aug 13 — IV 41% · EM ±4.8%Aug 14 — IV 55% · EM ±6.1%Aug 17 — IV 60% · EM ±5.0%Aug 18 — IV 56% · EM ±4.0%Aug 19 — IV 85% · EM ±5.0%Aug 20 — IV 142% · EM ±5.9%Aug 24 — IV 23% · EM ±4.9%Aug 25 — IV 24% · EM ±4.8%Aug 26 — IV 24% · EM ±4.8%Aug 27 — IV 20% · EM ±3.8%Aug 28 — IV 38% · EM ±7.3%Aug 31 — IV 27% · EM ±4.8%Sep 01 — IV 40% · EM ±6.9%Sep 02 — IV 41% · EM ±6.9%Sep 03 — IV 45% · EM ±7.3%Sep 04 — IV 46% · EM ±7.2%Sep 07 — IV 52% · EM ±7.2%Sep 08 — IV 36% · EM ±4.8%Sep 09 — IV 53% · EM ±6.6%Sep 10 — IV 39% · EM ±4.6%Sep 11 — IV 60% · EM ±6.7%Sep 14 — IV 77% · EM ±6.4%Sep 15 — IV 54% · EM ±3.9%Sep 16 — IV 76% · EM ±4.5%Sep 17 — IV 162% · EM ±6.8%Sep 21 — IV 37% · EM ±7.7%Sep 22 — IV 33% · EM ±6.7%Sep 23 — IV 34% · EM ±6.8%Sep 24 — IV 35% · EM ±6.8%Sep 25 — IV 35% · EM ±6.7%Sep 28 — IV 39% · EM ±6.8%Sep 29 — IV 43% · EM ±7.4%Sep 30 — IV 54% · EM ±9.0%Oct 01 — IV 45% · EM ±7.2%Oct 02 — IV 31% · EM ±4.8%Oct 06 — IV 37% · EM ±4.9%Oct 07 — IV 63% · EM ±7.9%Oct 08 — IV 61% · EM ±7.2%

Sector peers

IBRX
ImmunityBio, Inc.
$10.3B $8.31-5.2%
TWST
Twist Bioscience Corporation
$12.5B $135.47-5.1%
APGE
Apogee Therapeutics, Inc.
$10.2B $135.07
HALO
Halozyme Therapeutics, Inc.
$12.6B $124.54+0.1%
KRYS
Krystal Biotech, Inc.
$9.6B $320.13-1.6%
QGEN
Qiagen N.V.
$9.2B $50.22+2.7%

TECH earnings FAQ

When is TECH's next earnings date?

Bio-Techne Corp is expected to report on November 4, 2026.

What is TECH's expected move for earnings?

Options currently price a move of about ±7.2%, or $5.21 per share either way from $72.62.

How does TECH stock usually react to earnings?

Across the last 6 reports the average next-day move was ±5.9%, up 3 times and down 3 times.

What EPS are analysts expecting from Bio-Techne Corp?

The consensus estimate is $0.40 per share, versus $0.36 a year ago.

What is TECH's implied volatility?

TECH's at-the-money implied volatility is about 61% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in